Sentinel lymph node molecular ultrastaging in patients with melanoma: A systematic review and meta-analysis of prognosis

Simone Mocellin, Dave S B Hoon, Pierluigi Pilati, Carlo R. Rossi, Donato Nitti

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: Molecular biology-based ultrastaging of cancer is already part of the standard management of patients with hematologic malignancies, whereas the evidence for solid tumors is much more debated. Polymerase chain reaction (PCR) -based detection of melanoma cells in sentinel lymph nodes (SLN) of patients with melanoma represents an appealing prognostic tool. However, no consensus exists on the clinical implementation of this prognostic indicator for the management of these patients. Methods: Twenty-two studies enrolling 4,019 patients who underwent SLN biopsy for clinical stage I to II cutaneous melanoma were reviewed. Correlation of PCR status with TNM stage, disease recurrence rates, and survival was assessed by means of association statistics and formal meta-analysis, respectively. Results: PCR status correlated with both TNM stage (stage I to II v III; PCR positivity, 95.1% v 46.6%; P <.0001) and disease recurrence (PCR positive v negative; relapse rate, 16.8% v 8.7%; P <.0001). PCR positivity was also associated with worse overall (hazard ratio [HR], 5.08; 95% CI, 1.83 to 14.08; P = .002) and disease-free (HR, 3.41; 95% CI, 1.86 to 6.24; P <.0001) survival. Statistical heterogeneity was significant, underscoring the variability among overall effect estimates across studies; metaregression and subgroup analysis did not identify clear-cut sources of heterogeneity, although some study design variables were suggested as potential causes. Conclusion: PCR status of SLN appears to have a clinically valuable prognostic power in patients with melanoma. Although the heterogeneity of the studies so far published warrants caution to avoid overestimating the favorable results of pooled data, our findings strongly support additional investigation in this field.

Original languageEnglish
Pages (from-to)1588-1595
Number of pages8
JournalJournal of Clinical Oncology
Volume25
Issue number12
DOIs
Publication statusPublished - Apr 20 2007

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Sentinel lymph node molecular ultrastaging in patients with melanoma: A systematic review and meta-analysis of prognosis'. Together they form a unique fingerprint.

Cite this